Alcoholic Intoxication, Chronic
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
However, they revealed a significant association between the NR4A2 gene haplotype and alcohol dependence, indicating that 2q22-q23 including the NR4A2 gene locus is a possible genomic region contributing to genetic susceptibility to alcohol dependence.
|
11840500 |
2002 |
Arthritis, Psoriatic
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
NURR1 was abundantly expressed in the inflammatory cells of both RA and PsA synovium.
|
11315917 |
2001 |
Arthritis, Psoriatic
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
MTX significantly suppresses expression of NURR1 in vivo in patients with active psoriatic arthritis (n = 10; p < 0.002) who were prescribed low-dose MTX for management of peripheral arthritis.
|
15972692 |
2005 |
PARKINSON DISEASE, LATE-ONSET
|
0.320 |
Biomarker
|
disease |
BEFREE |
We performed a mutation screen of NR4A2 (also known as NURR1) in 409 Parkinson's disease (PD) patients.
|
19429166 |
2009 |
PARKINSON DISEASE, LATE-ONSET
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
However, NURR1 (57.631% reduced in males; 28.93% in females) and FOXA1 (64.42% in males; 55.76% in females) mRNA expression did differ greatly between male and female PD patients.
|
28255498 |
2017 |
Cocaine Abuse
|
0.310 |
Biomarker
|
disease |
BEFREE |
In the present study, we show that each of these transcription factors is robustly expressed in adult dopamine neurons in human midbrain, and that cocaine abuse is associated with a significant decrease in the abundance of Nurr1 and Pitx3 in these cells.
|
15094491 |
2004 |
Language Disorders
|
0.310 |
Biomarker
|
group |
BEFREE |
Our findings of a de novo deletion of NR4A2 in an individual with mild intellectual disability and prominent speech and language impairment provides further evidence for NR4A2 haploinsufficiency being causative for neurodevelopmental and particularly language phenotypes.
|
28544326 |
2017 |
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
BEFREE |
Nurr1 protein in BA 9 was significantly lower in major depression (P<0.05) and lower at a trend level in schizophrenia (P=0.056) than in the controls.
|
16631355 |
2006 |
Abnormal behavior
|
0.310 |
Biomarker
|
phenotype |
BEFREE |
There is a highly homologous NURR1 gene in humans (formerly known as NOT) which therefore constitutes a good candidate gene for neurologic and psychiatric disorders with an involvement of the dopamine neuron system, such as Parkinson's disease, schizophrenia, and manic-depression.
|
11121187 |
2000 |
Major Depressive Disorder
|
0.310 |
Biomarker
|
disease |
BEFREE |
Nurr1 protein in BA 9 was significantly lower in major depression (P<0.05) and lower at a trend level in schizophrenia (P=0.056) than in the controls.
|
16631355 |
2006 |
Intellectual Disability
|
0.310 |
Biomarker
|
group |
BEFREE |
NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.
|
29770430 |
2018 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Our findings suggest that activation of Nurr1 might be therapeutically useful in Parkinson's disease.
|
11113533 |
2000 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Neuroprotective effect of olfactory ensheathing cells co-transfected with Nurr1 and Ngn2 in both in vitro and in vivo models of Parkinson's disease.
|
29291419 |
2018 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
The observed reduction in PBL NURR1 gene expression indicates possible systemic involvement in PD, and the finding may help identify individuals with PD and other disorders associated with impaired central DAergic system.
|
18684475 |
2008 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Taken together, these data suggest that C-DIM12 is an activator of Nurr1 that suppresses glial activation and neuronal loss in vivo after treatment with MPTP, and that this receptor could be an efficacious target for disease modification in individuals with Parkinson's disease and related disorders.
|
29626009 |
2018 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
This review highlights the recent progress in preclinical studies of Nurr1-based therapies and discusses the outlook of this emerging therapy as a promising new generation of PD medication.
|
27012974 |
2016 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
NURR1 alterations have been linked to DA-associated brain disorders, such as Parkinson's disease and schizophrenia.
|
31455763 |
2019 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Bis-indole derivatives including 1,1-bis(3'-indolyl)-1-(4-chlorophenyl)methane (DIM-C-pPhCl) and substituted quinolines such as chloroquine (CQ) and amodiaquine (AQ) are nuclear receptor 4A2 (NR4A2, Nurr1) ligands, and they exhibit anti-inflammatory activities in mouse and rat models of Parkinson's disease, respectively.
|
31102570 |
2019 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits.
|
12815740 |
2003 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that the NR4A2 IVS6 +18insG polymorphism may play a minor role in PD susceptibility among Taiwanese women.
|
17427185 |
2007 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Our results provide useful information that the NURR1 and PITX3 gene expression is decreased in the PBL of Chinese patients with PD, indicating their possible systemic involvement in PD.
|
22309633 |
2012 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
There is a highly homologous NURR1 gene in humans (formerly known as NOT) which therefore constitutes a good candidate gene for neurologic and psychiatric disorders with an involvement of the dopamine neuron system, such as Parkinson's disease, schizophrenia, and manic-depression.
|
11121187 |
2000 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Graphical Abstract In the rat rotenone model of Parkinson's disease (PD), Nurr1 expression was downregulated, GSK-3β was activated, and autophagic flux was inhibited.
|
29429051 |
2018 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
These results indicate that Ser125 is critical for basal and ERK1/2-induced NURR1 activity and suggest a role for this and other NURR1 mutations in the regulation of dopamine synthesis and predisposition to Parkinson's disease.
|
17890097 |
2008 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Altogether, the enhancement of tyrosine hydroxylase in naïve dopaminergic cells and the protective effects in a cellular model of Parkinson's disease suggest that full-length Nurr1 fusion protein may contribute to the development of a novel concept of protein-based therapy.
|
30121937 |
2019 |